Using 18F-FDG PET-CT to Detect Lung Disease in Systemic Sclerosis
Author Information
Author(s): Broens Bo, Nossent Esther J., Meijboom Lilian J., Zwezerijnen Gerben J. C., Spierings Julia, de Vries-Bouwstra Jeska, van Laar Jacob M., van der Laken Conny J., Voskuyl Alexandre E.
Primary Institution: Amsterdam UMC
Hypothesis
Can 18F-FDG PET-CT effectively assess the presence and extent of interstitial lung disease in patients with early severe diffuse cutaneous systemic sclerosis?
Conclusion
18F-FDG PET-CT can detect metabolic activity in the lungs of patients with early severe diffuse cutaneous systemic sclerosis and interstitial lung disease, correlating with higher ILD extent and lower DLCO%.
Supporting Evidence
- 18F-FDG uptake was significantly higher in the dorsobasal lung fields of patients with SSc-ILD compared to those without ILD and controls.
- Patients with extensive ILD showed higher 18F-FDG uptake and lower DLCO%.
- Ground-glass opacities corresponded to increased 18F-FDG uptake.
Takeaway
This study shows that a special scan can help doctors see lung problems in patients with a specific skin disease, even when the problems are just starting.
Methodology
A prospective, cross-sectional study involving 15 patients with SSc-ILD, 5 patients with SSc without ILD, and 7 controls, using 18F-FDG PET-CT and HRCT scans.
Limitations
Relatively small patient numbers limit regression analysis and there is a lack of follow-up data.
Participant Demographics
15 patients with SSc-ILD, 5 patients with SSc without ILD, and 7 controls; median age of SSc-ILD patients was 54 years.
Statistical Information
P-Value
p=0.03 and p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website